Background
What do we already know about this topic?
- Researchers have attempted to identify biomarkers in the headache field for decades.
- The majority of research has focused on migraine with little attention paid to cluster headache.
- The diagnostic criteria for migraine and cluster headache are distinct but biochemical levels similar.
- As yet, no biomarkers have been established in clinical practice, but calcitonin gene-related peptide (CGRP) is currently the most promising candidate.